Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Loss covered | |
| Loans and borrowings | $201,401 | |
| Capital expenditure | $10,396 | |
| Planned capital expenditure (next year) | $4,021 | |
| Revenue structure | Usługi związane ze sprzedażą wyrobów farmaceutycznych |
Filing timeliness
Financial statements were filed on time, on average 34 days early.
- 2025filed
- 202401/07/2025
- 202304/07/2024
- 202228/06/2023
- 202123/06/2022
- 202029/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Public procurement
Maxwit is the contractor in one public sector contract, worth USD 135.06.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Jul 3, 2026 | Purchase of medication for a dog | $135.06 | Komenda Wojewódzka Policji |
National Health Fund (NFZ) contracts
Maxwit has been an NFZ healthcare provider since 2024. In 2026 it is performing 6 contracts with a total value of USD 22.76k. All its contracts were worth USD 22.76k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | zachodniopomorskie | 3 | USD 22.36k |
| Pilot programmes | zachodniopomorskie | 3 | USD 405.18 |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, declarations of will on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy. A commercial proxy may represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksandra Złotnickaage 72 | 91 | $1,229.07 | 91% |
Others | 9 | $121.56 | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Elixirsp. z o.o. | 1,350.62 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2017-05-10.
35 1240 3813 1111 0010 7354 7034
28 1020 1068 0000 1402 0399 4415
Debt
No entries in the National Debtors Register (KRZ).
Public aid
7 public aid cases recorded, with a total value of $30,610.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 2, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,903$2,903 | Starosta Powiatu Łobez | |
| Aug 12, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $7,013$7,013 | STAROSTA STARGARDZKI | |
| Apr 19, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,798$1,798 | Starosta Powiatu Myślibórz |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
FAQ
Last updated: 2026-04-22